Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serlopitant Phase 2 in Chronic Pruritus
NCT01951274Phase 2Completed
- Sponsor
- Vyne Therapeutics
- Start
- Oct 2013
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of serlopitant in chronic pruritus (CP) (4 arms), sponsored by Vyne Therapeutics. Primary endpoint: Visual Analog Scale at 6 weeks. Started Oct 2013; status: completed.
02
Drugs
serlopitant
03
Conditions
chronic pruritus (CP)
Beyond the preview
Go deeper on NCT01951274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01951274.